Apretude (cabotegravir)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Apretude (cabotegravir), covering 2019-06-13 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 [Phase 3]